ClinConnect ClinConnect Logo
Search / Trial NCT07010601

Tobacco Product Susceptibility and Substitutability by Rurality and Alcohol Use

Launched by MARK J RZESZUTEK, PHD · May 29, 2025

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This clinical trial is studying how living in rural areas and alcohol use may affect people's chances of starting or stopping tobacco products, like cigarettes and e-cigarettes. Researchers want to understand how these factors influence people's interest in new tobacco products and their likelihood of switching to products that help them quit smoking. They will look at different types of tobacco products, including those with high and low levels of nicotine, and see how people respond to them.

To participate, you need to be at least 21 years old and live in the USA. There are different groups in the study: one for people who smoke or use e-cigarettes frequently, another for those who haven't used tobacco products in the past month, and two groups based on alcohol use. If you’re interested, the study will involve some assessments and surveys about your tobacco and alcohol use, but you won’t be required to change your habits. This research is important because it aims to better understand how to help people, especially in rural areas, reduce their tobacco use.

Gender

ALL

Eligibility criteria

  • Cigarette/E-Cigarette Users
  • Inclusion Criteria:
  • 21 years of age or older
  • Smoke cigarettes or use e-cigarettes 25 or more days a month
  • Cigarette/E-Cigarette Non-Users
  • Inclusion Criteria:
  • 21 years of age or older
  • Do not report using an e-cigarette or cigarette in the past month
  • Risky Alcohol Users
  • Inclusion Criteria:
  • 21 years of age or older
  • A score of 8 or higher on the Alcohol Use Disorder Identification Test
  • Non-Risky Alcohol Users
  • Inclusion Criteria:
  • 21 years of age or older
  • A score of 7 or lower on the Alcohol Use Disorder Identification Test
  • All groups
  • Inclusion Criteria:
  • Located in the USA
  • At least 100 complete studies on Prolific
  • Exclusion Critera:
  • Failing attention checks during the screener

About Mark J Rzeszutek, Phd

Mark J. Rzeszutek, PhD, is a distinguished clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With a strong background in biomedical sciences and extensive experience in trial design and implementation, Dr. Rzeszutek leads innovative studies that focus on the development of novel therapeutics and treatment strategies. His expertise encompasses various therapeutic areas, and he is dedicated to ensuring rigorous ethical standards and regulatory compliance throughout the research process. Dr. Rzeszutek's collaborative approach fosters partnerships with academic institutions and industry leaders, driving forward the mission to translate scientific discoveries into real-world applications.

Locations

Lexington, Kentucky, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported